Procurement of Anti-Cancer Drugs for Kerala, 2026-27

Work Description - Re-tender For The Procurement Of Anti Cancer Drugs For The Year 2026-27

This tender, initiated by Kerala Medical Services Corporation Ltd (KMSCL) under the State Govt. and UT, is a re-tender for the critical procurement of anti-cancer drugs for the fiscal year 2026-27. The procurement falls under the "Goods" tender category and specifically within the "Health & Medicines" product category. Interested parties are invited to submit their bids for this open tender, with a tender reference number of KMSCL/ED/ACD/RT/2026/019. The tender documents are available for download from August 11, 2026, at 06:00 PM until August 21, 2026, at 05:00 PM. Bids can be submitted starting from August 11, 2026, at 06:00 PM, with the submission deadline set for August 21, 2026, at 05:00 PM. The bid opening will take place on August 24, 2026, at 11:00 AM at the location of Thycaud, Thiruvananthapuram. A mandatory Earnest Money Deposit (EMD) of ₹50,000 is required, with options for EMD exemption or submission through BG/ST. The tender fee is ₹29,795, inclusive of GST. Bidders are required to submit their proposals in two covers: Cover 1 for Fee/Pre-Qual/Technical documents and Cover 2 for the financial bid. The contract form is item-wise, and the period of work is for 365 days, with a bid validity of 180 days. Further details regarding the specific documentary requirements and specifications for the anti-cancer drugs are available within the comprehensive tender document.